RecruitingISRCTN87426672
Feasibility of sertraline versus placebo for depression in Huntington’s disease
About this title
Developing EVIdence for AntidepreSsant ChoicE to Treat Depression in Huntington’s Disease
Read the official source — ISRCTN87426672Research studyAges 18–100United Kingdom
Understand this study
Who could participate?
Listed age limits: 18 years to 100 years.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Cardiff University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- From 18 Years to 100 Years
- Official registry ID
- ISRCTN87426672
- Official title
Show the full official title
Anti-depressants for depression in Huntington's disease
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cardiff University, a university.
Who can participate?
Listed age limits: 18 years to 100 years.
Is this study still recruiting?
The registry lists this study as recruiting.
